| Financial Year |
March 31 2023 |
| Monetary Funds |
1,278,955,852.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,698,051.14 |
| Accounts Receivable |
4,395,319,411.83 |
| Advances to Suppliers |
204,157,963.66 |
| Other Receivables |
830,834,352.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
435,185,895.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
574,788,795.18 |
| Total Current Assets |
7,797,128,907.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
429,104,735.98 |
| Long-term Equity Investment |
932,285,431.33 |
| Investment Properties |
-- |
| Fixed Assetes |
2,098,726,223.92 |
| Under-construction Projects |
643,707,120.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,022,852,413.87 |
| R&D expenses |
-- |
| Goodwill |
237,498,694.52 |
| Long-Term Deferred and Prepaid Expenses |
66,439,552.59 |
| Deferred Income Tax Assets |
569,251,282.57 |
| Other Non-Current Assets |
2,028,777,104.36 |
| Sub-Total of Non-Current Assets |
18,120,411,232.01 |
| Total Assets |
25,917,540,139.13 |
| Short-Term Loans |
2,650,246,352.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,113,765,816.04 |
| Accounts Received In Advance |
213,904.78 |
| Employee Compensation Payable |
276,248,820.75 |
| Taxes Payable |
174,650,059.98 |
| Interest Payable |
-- |
| Dividend Payable |
9,563,309.49 |
| Other payables |
1,317,622,715.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,222,822.00 |
| Other Current Liabilities |
36,379,556.68 |
| Sub-Total of Current Liabilities |
7,779,256,319.36 |
| Long-term Loans |
5,440,686,159.39 |
| Bonds Payable |
154,950,685.00 |
| Long-Term Accounts Payable |
282,089,074.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
269,011,188.05 |
| Deferred Income Tax Liabilities |
61,452,064.98 |
| Other Non-Current Liabilities |
1,475,000,000.00 |
| Sub-Total of Non-Current Liabilities |
7,917,166,924.29 |
| Total Liabilities |
15,696,423,243.65 |
| Paid-In Capital(Or Share Stock) |
1,425,353,248.00 |
| Capital Surplus |
6,766,788,033.75 |
| Surplus Reserve |
565,781,054.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,896,938,964.16 |
| Minority Stockholder's Interest |
2,867,385,201.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,353,731,694.39 |
| Owner's Equity（Stockholder's Equity） |
10,221,116,895.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,917,540,139.13 |
